Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis

Background: Ligustrazine injection has been widely used as adjunctive therapy in the treatment of acute cerebral infarction (ACI) during the past decades in China, but its clinical efficacy is not yet well confirmed. This study aims to evaluate the efficacy of ligustrazine injection as adjunctive th...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huikai Shao, Xia He, Lijuan Zhang, Shan Du, Xiaoqing Yi, Xiaojiao Cui, Xinxia Liu, Shengfeng Huang, Rongsheng Tong
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/603e55e8e1f44651a2e206a6296802cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:603e55e8e1f44651a2e206a6296802cc
record_format dspace
spelling oai:doaj.org-article:603e55e8e1f44651a2e206a6296802cc2021-11-22T07:22:53ZEfficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis1663-981210.3389/fphar.2021.761722https://doaj.org/article/603e55e8e1f44651a2e206a6296802cc2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.761722/fullhttps://doaj.org/toc/1663-9812Background: Ligustrazine injection has been widely used as adjunctive therapy in the treatment of acute cerebral infarction (ACI) during the past decades in China, but its clinical efficacy is not yet well confirmed. This study aims to evaluate the efficacy of ligustrazine injection as adjunctive therapy for ACI.Methods: Databases including China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), PubMed, Medline, Google Scholar, Chinese Biomedical Literature Database, Cochrane Library, Embase, Sino-Med, Wanfang Database, and Chinese Science Citation Database were systematically searched for the published randomized controlled trials (RCTs) on ligustrazine injection in the treatment of ACI until November 2020. Meta-analysis was performed on the primary outcome measure (i.e., clinical effective rate) and the secondary outcome measure [i.e., neurological deficit score (NDS), fibrinogen, low shear blood viscosity (LBV), and high shear blood viscosity (HBV)]. The quality of the included RCTs was assessed according to the M scoring system (the refined Jadad scale). Sensitivity analysis and subgroup analysis were conducted according to the methodological quality, years of publication, and sample size.Results: Nineteen RCTs, containing 2022 patients, were included in this study. Meta-analysis indicated that ligustrazine injection combined with Western medicine could achieve a better effect in the treatment of ACI than using Western medicine alone in terms of clinical effective rate (RR = 1.24; 95% CI, 1.19–1.29), NDS (MD = −3.88; 95%CI, −4.51 to −3.61), fibrinogen (MD = −0.59; 95% CI, −0.76 to −0.42), LBV (MD = −2.11; 95% CI, −3.16 to −1.06), and HBV (MD = −0.88; 95% CI, −1.20 to −0.55).Conclusions: This research indicated that ligustrazine injection as adjunctive therapy seemed to be more effective than using western medicine alone in treating ACI. However, more evidence is required to confirm the efficacy of ligustrazine injection due to the low methodological quality of the included RCTs.Huikai ShaoHuikai ShaoXia HeXia HeLijuan ZhangLijuan ZhangShan DuShan DuXiaoqing YiXiaoqing YiXiaojiao CuiXiaojiao CuiXinxia LiuXinxia LiuShengfeng HuangRongsheng TongRongsheng TongFrontiers Media S.A.articleligustrazine injectionadjunctive therapyacute cerebral infarctionsystematic reviewmeta-analysisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic ligustrazine injection
adjunctive therapy
acute cerebral infarction
systematic review
meta-analysis
Therapeutics. Pharmacology
RM1-950
spellingShingle ligustrazine injection
adjunctive therapy
acute cerebral infarction
systematic review
meta-analysis
Therapeutics. Pharmacology
RM1-950
Huikai Shao
Huikai Shao
Xia He
Xia He
Lijuan Zhang
Lijuan Zhang
Shan Du
Shan Du
Xiaoqing Yi
Xiaoqing Yi
Xiaojiao Cui
Xiaojiao Cui
Xinxia Liu
Xinxia Liu
Shengfeng Huang
Rongsheng Tong
Rongsheng Tong
Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
description Background: Ligustrazine injection has been widely used as adjunctive therapy in the treatment of acute cerebral infarction (ACI) during the past decades in China, but its clinical efficacy is not yet well confirmed. This study aims to evaluate the efficacy of ligustrazine injection as adjunctive therapy for ACI.Methods: Databases including China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), PubMed, Medline, Google Scholar, Chinese Biomedical Literature Database, Cochrane Library, Embase, Sino-Med, Wanfang Database, and Chinese Science Citation Database were systematically searched for the published randomized controlled trials (RCTs) on ligustrazine injection in the treatment of ACI until November 2020. Meta-analysis was performed on the primary outcome measure (i.e., clinical effective rate) and the secondary outcome measure [i.e., neurological deficit score (NDS), fibrinogen, low shear blood viscosity (LBV), and high shear blood viscosity (HBV)]. The quality of the included RCTs was assessed according to the M scoring system (the refined Jadad scale). Sensitivity analysis and subgroup analysis were conducted according to the methodological quality, years of publication, and sample size.Results: Nineteen RCTs, containing 2022 patients, were included in this study. Meta-analysis indicated that ligustrazine injection combined with Western medicine could achieve a better effect in the treatment of ACI than using Western medicine alone in terms of clinical effective rate (RR = 1.24; 95% CI, 1.19–1.29), NDS (MD = −3.88; 95%CI, −4.51 to −3.61), fibrinogen (MD = −0.59; 95% CI, −0.76 to −0.42), LBV (MD = −2.11; 95% CI, −3.16 to −1.06), and HBV (MD = −0.88; 95% CI, −1.20 to −0.55).Conclusions: This research indicated that ligustrazine injection as adjunctive therapy seemed to be more effective than using western medicine alone in treating ACI. However, more evidence is required to confirm the efficacy of ligustrazine injection due to the low methodological quality of the included RCTs.
format article
author Huikai Shao
Huikai Shao
Xia He
Xia He
Lijuan Zhang
Lijuan Zhang
Shan Du
Shan Du
Xiaoqing Yi
Xiaoqing Yi
Xiaojiao Cui
Xiaojiao Cui
Xinxia Liu
Xinxia Liu
Shengfeng Huang
Rongsheng Tong
Rongsheng Tong
author_facet Huikai Shao
Huikai Shao
Xia He
Xia He
Lijuan Zhang
Lijuan Zhang
Shan Du
Shan Du
Xiaoqing Yi
Xiaoqing Yi
Xiaojiao Cui
Xiaojiao Cui
Xinxia Liu
Xinxia Liu
Shengfeng Huang
Rongsheng Tong
Rongsheng Tong
author_sort Huikai Shao
title Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
title_short Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
title_full Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
title_fullStr Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
title_full_unstemmed Efficacy of Ligustrazine Injection as Adjunctive Therapy in Treating Acute Cerebral Infarction: A Systematic Review and Meta-Analysis
title_sort efficacy of ligustrazine injection as adjunctive therapy in treating acute cerebral infarction: a systematic review and meta-analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/603e55e8e1f44651a2e206a6296802cc
work_keys_str_mv AT huikaishao efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT huikaishao efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xiahe efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xiahe efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT lijuanzhang efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT lijuanzhang efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT shandu efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT shandu efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xiaoqingyi efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xiaoqingyi efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xiaojiaocui efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xiaojiaocui efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xinxialiu efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT xinxialiu efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT shengfenghuang efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT rongshengtong efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
AT rongshengtong efficacyofligustrazineinjectionasadjunctivetherapyintreatingacutecerebralinfarctionasystematicreviewandmetaanalysis
_version_ 1718417858094956544